Protocol for Drug Use Investigation of Follistim Injection (Study P06132)(COMPLETED)

CompletedOBSERVATIONAL
Enrollment

384

Participants

Timeline

Start Date

July 31, 2007

Primary Completion Date

March 31, 2009

Study Completion Date

March 31, 2009

Conditions
Anovulation
Interventions
DRUG

Follitropin beta

For subcutaneous or intramuscular injection, the usual dosage is 50 IU of follitropin beta (recombinant) once daily for 7 days. The dosage should be adjusted subsequently while monitoring the development of follicles (dose increase by 25 IU every 7 days if the response of the ovaries is poor) and, after confirming presence of follicles of 18 mm or larger in mean diameter by the ultrasonic tomography, ovulation is induced by the administration of a human chorionic gonadotropin preparation.

All Listed Sponsors
lead

Organon and Co

INDUSTRY

NCT00920634 - Protocol for Drug Use Investigation of Follistim Injection (Study P06132)(COMPLETED) | Biotech Hunter | Biotech Hunter